This invention is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I), to processes for their preparation, to pharmaceutical compositions comprising them, and to their use in therapy.
这项发明涉及具有一般式(I)的新p38丝裂原活化蛋白激酶
抑制剂,涉及它们的制备方法,包括它们的药物组合物,以及它们在治疗中的应用。